Dr. Peter Vansteenkiste - Nucleaire Geneeskunde (SRL)

Active

VAT

BE 0831.923.171

Address

Winkelstraat(LST) 9

2811 Mechelen

Established

15-12-2010

Principal activity

Specialist medical practice activities

Try for free

Crisis resilience of Dr. Peter Vansteenkiste - Nucleaire Geneeskunde

Which companies are best armed against current economic trends and the energy crisis?

2022		2021		2020		2019
Profit/Loss	€278,693	52%	€182,896	102%	€90,475	36%	€66,569
Equity	€782,988	38%	€569,295	7%	€533,900	20%	€443,424
Gross margin	€408,085	64%	€248,678	49%	€166,777	25%	€133,809

Publications in the Belgian Official Journal for Dr. Peter Vansteenkiste - Nucleaire Geneeskunde

Type	Date	Pdf	Subject
	01-03-2023		Modification Legal Form - Registered Office - Resignations - Appointments (NL)
	17-12-2010		Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Sources

Frequently asked questions

What is the VAT number of Dr. Peter Vansteenkiste - Nucleaire Geneeskunde?

The VAT number of Dr. Peter Vansteenkiste - Nucleaire Geneeskunde is BE0831923171.

When was Dr. Peter Vansteenkiste - Nucleaire Geneeskunde founded?

Dr. Peter Vansteenkiste - Nucleaire Geneeskunde was founded on 15-12-2010.

What is the address of Dr. Peter Vansteenkiste - Nucleaire Geneeskunde?

The current registered office of Dr. Peter Vansteenkiste - Nucleaire Geneeskunde is located at Winkelstraat(LST) 9, 2811 Mechelen.

When was the last time Dr. Peter Vansteenkiste - Nucleaire Geneeskunde filed their annual financial statements?

The most recent financial statements of Dr. Peter Vansteenkiste - Nucleaire Geneeskunde were filed on 02-07-2023. You can view them here.

How many employees does Dr. Peter Vansteenkiste - Nucleaire Geneeskunde have?

There are currently no employees working at Dr. Peter Vansteenkiste - Nucleaire Geneeskunde or no workforce information is available.

What is the annual turnover of Dr. Peter Vansteenkiste - Nucleaire Geneeskunde?

At the time of its most recent financial statements, Dr. Peter Vansteenkiste - Nucleaire Geneeskunde did not publish any turnover figures. Dr. Peter Vansteenkiste - Nucleaire Geneeskunde reported a gross margin of €408,085.19.